![](/study/2016-2017/files/study.2016-2017/exclamation-point-small.png)
Note: This is the 2014–2015 edition of the eCalendar. Update the year in your browser's URL bar for the most recent version of this page, or click here to jump to the newest eCalendar.
Note: This is the 2014–2015 edition of the eCalendar. Update the year in your browser's URL bar for the most recent version of this page, or click here to jump to the newest eCalendar.
The Department of Pharmacology and Therapeutics offers training leading to M.Sc. (Thesis) and Ph.D. degrees.
The Department also offers the Chemical Biology Interdisciplinary Graduate Option, together with the Departments of Biochemistry and Chemistry. Students interested in training in this option must first be accepted for graduate studies by one of the participating departments. Information on this option can be found at www.mcgill.ca/biochemistry/graduate-studies-2/chemicalbiology.
Pharmacology is a multidisciplinary science that deals with all aspects of drugs and their interactions with living organisms. Thus, pharmacologists study the physical and chemical properties of drugs, their biochemical and physiological effects, mechanisms of action, pharmacokinetics, and therapeutic and other uses. The Department offers broad exposure and training in both basic and clinical research in a range of areas of specialty, including neuropharmacology, reproductive, endocrine, receptor, cardiovascular, cancer, developmental, autonomic, clinical, and biochemical pharmacology, molecular biology, and toxicology.
The present 52 full and affiliate members of the Department have research laboratories located in the McIntyre Medical Sciences Building and in a variety of hospitals, institutes, and industry including the Douglas Hospital Research Centre, Allan Memorial Institute, Montreal Children's Hospital, Montreal General Hospital, Royal Victoria Hospital, Montreal Heart Institute, Lady Davis Research Institute, Pfizer Canada, and Merck Frosst Canada Inc. (Note that MUHC-affiliated hospitals and institutes are scheduled to move to the new Glen site in June 2015. Buildings and room numbers are to be confirmed.) The participation of researchers from both industry and government ensures the relevance of the Department's applications-oriented training programs.
Master of Science (M.Sc.); Pharmacology (Thesis) (45 credits) |
---|
The objective of the M.Sc. (Thesis) and Ph.D. degree training programs is to provide in-depth independent research experience in a specific area of pharmacology. |
Master of Science (M.Sc.); Pharmacology (Thesis) — Chemical Biology (47 credits) |
The Chemical Biology Thematic Group is engaged in a diverse range of research topics that span structural biology, enzymology, nucleic acid research, signalling pathways, single molecule biophysics, and biophysical chemistry of living tissues. Among the themes that unite the research being performed in this group is trying to learn new chemistry and physics from biological systems. We have projects relating to pharmaceutically relevant enzymes such as those involved in drug metabolism and antibiotic resistance; development of therapeutic agents in the control of inflammation, cancer, and viral infections; the chemical biology of NO; quantification of bioenergetic markers of metabolism; self-assembly mechanisms of the HIV-1 virion capsid; liposome microarray systems to address membrane protein dynamics and recognition; studies on reactive oxygen species translocation across the aqueous/lipid membrane interface; RNAi/antisense technologies; dynamic combinatorial chemistry; protein dynamics and function; mechanistic aspects involved in cellular adhesion and transport in membrane and zeolite channels; and cutting-edge microscopes used to examine transport, motility, and reactivity in cells. |
Doctor of Philosophy (Ph.D.); Pharmacology |
The objective of the M.Sc. (Thesis) and Ph.D. degree training programs is to provide in-depth independent research experience in a specific area of pharmacology. |
Doctor of Philosophy (Ph.D.); Pharmacology — Chemical Biology |
The Chemical Biology Thematic Group is engaged in a diverse range of research topics that span structural biology, enzymology, nucleic acid research, signalling pathways, single molecule biophysics, and biophysical chemistry of living tissues. Among the themes which unite the research being performed in this group is the attempt to learn new chemistry and physics from biological systems. We have projects relating to pharmaceutically relevant enzymes such as those involved in drug metabolism and antibiotic resistance; development of therapeutic agents in the control of inflammation, cancer and viral infections; the chemical biology of NO; quantification of bioenergetic markers of metabolism; self-assembly mechanisms of the HIV-1 virion capsid; liposome microarray systems to address membrane protein dynamics and recognition; studies on reactive oxygen species translocation across the aqueous/lipid membrane interface; RNAi/antisense technologies; dynamic combinatorial chemistry; protein dynamics and function; mechanistic aspects involved in cellular adhesion and transport in membrane and zeolite channels; and cutting-edge microscopes used to examine transport, motility, and reactivity in cells. |
Candidates are required to hold a B.Sc. degree in a discipline relevant to the proposed field of study; those with the M.D., D.D.S., or D.V.M. degrees are also eligible to apply. A background in the health sciences is recommended, but programs in biology, chemistry, mathematics, and physical sciences may be acceptable.
Admission is based on a student's academic record, letters of assessment, and, whenever possible, interviews with staff members. Students are required to take the Graduate Record Examination Aptitude Test (GRE) and the Test of English as a Foreign Language (TOEFL) or the equivalent, except as follows: in accordance with ƽÌØÎå²»ÖÐ policy, only those whose mother tongue is English, who graduated from a recognized Canadian institution (anglophone or francophone), or who completed an undergraduate or graduate degree at a recognized foreign institution where English is the language of instruction are exempt from providing proof of competency in English.
Inquiries relating to all aspects of graduate study should be directed to the Graduate Coordinator, Department of Pharmacology and Therapeutics, as early as possible in each academic year.
Admissions Requirements – Chemical Biology Option
As for the regular graduate programs of the participating departments, acceptance into the Chemical Biology option consists of two steps:
ƽÌØÎå²»ÖÐ’s online application form for graduate program candidates is available at www.mcgill.ca/gradapplicants/apply.
See Application Procedures for detailed application procedures.
The application deadlines listed here are set by the Department of Pharmacology and Therapeutics and may be revised at any time. Applicants must verify all deadlines and documentation requirements well in advance on the appropriate ƽÌØÎå²»ÖÐ departmental website; please consult the list at www.mcgill.ca/gps/contact/graduate-program.
Canadian | International | Special/Exchange/Visiting |
---|---|---|
Fall: June 1 | Fall: March 15 | Fall: March 15 |
Winter: Oct. 15 | Winter: Sept. 15 | Winter: Same as Canadian/International |
Summer: N/A | Summer: N/A | Summer: N/A |
Please refer to our website (www.mcgill.ca/pharma) for complete deadlines.
Admission to graduate studies is competitive; accordingly, late and/or incomplete applications are considered only as time and space permit.
Chair |
---|
G. Multhaup |
Graduate Program Director |
D. Bowie |
Emeritus Professors |
R. Capek; M.D., Ph.D.(Prague) |
H.H. Zingg; M.D., Ph.D.(McG.) |
Professors |
G. Almazan; Ph.D.(McG.) |
P.B.S. Clarke; M.A.(Camb.), Ph.D.(Lond.) |
A.C. Cuello; M.D.(Buenos Aires), M.A., D.Sc.(Oxf.), F.R.S.C. |
B.F. Hales; Ph.D.(McG.) |
T. Hébert; Ph.D.(Tor.) |
D. Maysinger; Ph.D.(USC) |
P.J. McLeod; M.D.(Manit.), F.R.C.P.(C) |
G. Multhaup; Ph.D.(Cologne) |
A. Ribeiro-da-Silva; M.D., Ph.D.(Oporto) |
B. Robaire; Ph.D.(McG.) |
H. Saragovi; Ph.D.(Miami) |
M. Szyf; Ph.D.(Hebrew) |
J. Trasler; M.D.,C.M., Ph.D.(McG.) |
Associate Professors |
D. Bernard; Ph.D.(Johns Hop.) |
D. Bowie; B.Sc., Ph.D.(Lond.) |
A. McKinney; Ph.D.(Ulster) |
S. Nattel; M.D.,C.M.(McG.) |
A.L. Padjen; M.D., Ph.D.(Zagreb) |
E. Zorychta; Ph.D.(McG.) |
Assistant Professors |
L. Münter; Ph.D.(Free Univ., Berlin) |
J. Tanny; Ph.D.(Harv.) |
J.F. Trempe; Ph.D.(Oxf.) |
Associate Members |
M. Alaoui-Jamali; Ph.D.(Paris IV) |
M. Culty; Ph.D.(Fr.) |
G. Di Battista; B.Sc., Ph.D.(Montr.) |
L. Fellows; M.D., C.M.(McG.) Ph.D.(Oxf.) |
P. Fiset; M.D.(Laval), F.R.C.P.S.(C) |
S. Gauthier; M.D.(Montr.) |
T. Geary; Ph.D.(Mich.) |
B. Jean-Claude; Ph.D.(McG.) |
S. Kimmins; Ph.D.(Dal.) |
S. Laporte; Ph.D.(Sher.) |
C. O'Flaherty; Ph.D.(Buenos Aires) |
V. Pappadopoulis; Ph.D.(Univ. Pierre & Marie Curie) |
R. Prichard; Ph.D.(UNSW) |
S. Rousseau; Ph.D.(Laval) |
Y. Shir; M.D.(Israel), Ph.D.(Johns Hop.) |
L. Stone; Ph.D.(Minn.) |
M. Ware; M.B.B.S.(West Indies) |
T. P. Wong; Ph.D.(McG.) |
Adjunct Professors |
B. Allen, M. Bruno, S. Chemtob, Y. De Koninck, L. Garofalo, J.M.A. Laird, J. Mancini, K. Meerovitch, G. Miller, T. Sanderson |
For more information, see Master of Science (M.Sc.); Pharmacology (Thesis) (45 credits).
For more information, see Master of Science (M.Sc.); Pharmacology (Thesis) — Chemical Biology (47 credits).
For more information, see Doctor of Philosophy (Ph.D.); Pharmacology .
For more information, see Doctor of Philosophy (Ph.D.); Pharmacology — Chemical Biology.